Congenital disorders of glycosylation (CDG): Quo vadis?

Romain Péanne, Pascale de Lonlay, François Foulquier, Uwe Kornak, Dirk J. Lefeber, Eva Morava, Belén Pérez, Nathalie Seta, Christian Thiel, Emile Van Schaftingen, Gert Matthijs, Jaak Jaeken

Research output: Contribution to journalReview article

64 Scopus citations

Abstract

The survey summarizes in its first part the current status of knowledge on the Congenital Disorders of Glycosylation (CDG) with regard to their phenotypic spectrum, diagnostic and therapeutic strategies, and pathophysiology. It documents the clinical and basic research activities, and efforts to involve patients and their families. In the second part, it tries to look into the future of CDG. More specific biomarkers are needed for fast CDG diagnosis and treatment monitoring. Whole genome sequencing will play an increasingly important role in the molecular diagnosis of unsolved CDG. Epigenetic defects are expected to join the rapidly expanding genetic and allelic heterogeneity of the CDG family. Novel treatments are urgently needed particularly for PMM2-CDG, the most prevalent CDG. Patient services such as apps should be developed e.g. to document the natural history and monitor treatment. Networking (EURO-CDG, the European Reference Networks (MetabERN)) is an efficient tool to disseminate knowledge and boost collaboration at all levels. The final goal is of course to improve the quality of life of the patients and their families.

Original languageEnglish (US)
Pages (from-to)643-663
Number of pages21
JournalEuropean Journal of Medical Genetics
Volume61
Issue number11
DOIs
StatePublished - Nov 2018

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Congenital disorders of glycosylation (CDG): Quo vadis?'. Together they form a unique fingerprint.

  • Cite this

    Péanne, R., de Lonlay, P., Foulquier, F., Kornak, U., Lefeber, D. J., Morava, E., Pérez, B., Seta, N., Thiel, C., Van Schaftingen, E., Matthijs, G., & Jaeken, J. (2018). Congenital disorders of glycosylation (CDG): Quo vadis? European Journal of Medical Genetics, 61(11), 643-663. https://doi.org/10.1016/j.ejmg.2017.10.012